HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia.
Hu X, Fu W, Wang L, Gao L, Lü S, Xi H, Qiu H, Chen L, Chen J, Ni X, Xu X, Zhang W, Yang J, Wang J, Song X.
Hu X, et al.
Oncotarget. 2016 Jan 19;7(3):3623-34. doi: 10.18632/oncotarget.6211.
Oncotarget. 2016.
PMID: 26497216
Free PMC article.